Cargando…
Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury
Dapagliflozin, a new type of drug used to treat diabetes mellitus (DM), is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Although some studies showed that SGLT2 inhibition attenuated reactive oxygen generation in diabetic kidney the role of SGLT2 inhibition is unknown. We evaluated whether SLT...
Autores principales: | Chang, Yoon-Kyung, Choi, Hyunsu, Jeong, Jin Young, Na, Ki-Ryang, Lee, Kang Wook, Lim, Beom Jin, Choi, Dae Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938401/ https://www.ncbi.nlm.nih.gov/pubmed/27391020 http://dx.doi.org/10.1371/journal.pone.0158810 |
Ejemplares similares
-
Correction: Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury
por: Chang, Yoon-Kyung, et al.
Publicado: (2016) -
Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice
por: Chung, Sarah, et al.
Publicado: (2016) -
Pretreatment with Darbepoetin Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity
por: Choi, Dae Eun, et al.
Publicado: (2009) -
Omega-3 Fatty Acids Attenuate Renal Fibrosis via AMPK-Mediated Autophagy Flux Activation
por: Han, Suyeon, et al.
Publicado: (2023) -
Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E(2) Receptor EP4 Pathway
por: Hong, Yu Ah, et al.
Publicado: (2017)